10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001558370-22-016640 |
| Period End Date | 20220930 |
| Filing Date | 20221107 |
| Fiscal Year | 2023 |
| Fiscal Period | Q1 |
| XBRL Instance | tmb-20220930x10q_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
89 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Accounts receivable, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$2.57M | USD | Point-in-time |
| Accounts receivable, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$2.50M | USD | Point-in-time |
| Undesignated capital stock, no par (in dollars per share) |
UndesignatedCapitalStockNoParValue
|
- | USD | Point-in-time |
| Undesignated capital stock, no par (in dollars per share) |
UndesignatedCapitalStockNoParValue
|
- | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$172.57M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$165.26M | USD | Point-in-time |
| Short-term available-for-sale investments |
ShortTermInvestments
|
$37.82M | USD | Point-in-time |
| Undesignated capital stock, shares authorized (in shares) |
UndesignatedCapitalStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Short-term available-for-sale investments |
ShortTermInvestments
|
$74.46M | USD | Point-in-time |
| Undesignated capital stock, shares authorized (in shares) |
UndesignatedCapitalStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts of $2,496 and $2,568, respectively |
AccountsReceivableNetCurrent
|
$194.55M | USD | Point-in-time |
| Undesignated capital stock, shares issued (in shares) |
UndesignatedCapitalStockSharesIssued
|
0.00 | shares | Point-in-time |
| Undesignated capital stock, shares issued (in shares) |
UndesignatedCapitalStockSharesIssued
|
0.00 | shares | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts of $2,496 and $2,568, respectively |
AccountsReceivableNetCurrent
|
$174.17M | USD | Point-in-time |
| Undesignated capital stock, shares outstanding (in shares) |
UndesignatedCapitalStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Inventories |
InventoryNet
|
$141.12M | USD | Point-in-time |
| Inventories |
InventoryNet
|
$150.01M | USD | Point-in-time |
| Undesignated capital stock, shares outstanding (in shares) |
UndesignatedCapitalStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$24.77M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$22.86M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$605.56M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$552.03M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
39.23M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$223.24M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
39.16M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$224.10M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
39.23M | shares | Point-in-time |
| Right of use asset |
OperatingLeaseRightOfUseAsset
|
$65.56M | USD | Point-in-time |
| Right of use asset |
OperatingLeaseRightOfUseAsset
|
$69.75M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
39.16M | shares | Point-in-time |
| Goodwill |
Goodwill
|
$865.42M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$822.10M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$585.53M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$531.52M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$46.83M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$53.90M | USD | Point-in-time |
| Total assets |
Assets
|
$2.29B | USD | Point-in-time |
| Total assets |
Assets
|
$2.35B | USD | Point-in-time |
| Trade accounts payable |
AccountsPayableCurrent
|
$30.48M | USD | Point-in-time |
| Trade accounts payable |
AccountsPayableCurrent
|
$33.87M | USD | Point-in-time |
| Salaries, wages and related accruals |
EmployeeRelatedLiabilitiesCurrent
|
$32.56M | USD | Point-in-time |
| Salaries, wages and related accruals |
EmployeeRelatedLiabilitiesCurrent
|
$61.95M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$13.79M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$17.89M | USD | Point-in-time |
| Contract liabilities |
ContractWithCustomerLiabilityCurrent
|
$22.06M | USD | Point-in-time |
| Contract liabilities |
ContractWithCustomerLiabilityCurrent
|
$23.41M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$17.27M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$13.24M | USD | Point-in-time |
| Operating lease liabilities - current |
OperatingLeaseLiabilityCurrent
|
$12.12M | USD | Point-in-time |
| Operating lease liabilities - current |
OperatingLeaseLiabilityCurrent
|
$11.93M | USD | Point-in-time |
| Contingent consideration payable |
BusinessCombinationContingentConsiderationLiabilityCurrent
|
$7.40M | USD | Point-in-time |
| Current portion of long-term debt obligations |
LongTermDebtCurrent
|
$12.50M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.24M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.96M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$137.63M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$176.02M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$98.99M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$112.92M | USD | Point-in-time |
| Long-term debt obligations |
LongTermDebtAndCapitalLeaseObligations
|
$264.66M | USD | Point-in-time |
| Long-term debt obligations |
LongTermDebtAndCapitalLeaseObligations
|
$243.41M | USD | Point-in-time |
| Long-term contingent consideration payable |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
$5.00M | USD | Point-in-time |
| Long-term contingent consideration payable |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
$8.10M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$64.76M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$58.13M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$11.50M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$12.24M | USD | Point-in-time |
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding |
UndesignatedCapitalStockValue
|
- | USD | Point-in-time |
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding |
UndesignatedCapitalStockValue
|
- | USD | Point-in-time |
| Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,232,094 and 39,160,000, respectively |
CommonStockValue
|
$392.00K | USD | Point-in-time |
| Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,232,094 and 39,160,000, respectively |
CommonStockValue
|
$392.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$653.66M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$680.06M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$1.12B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$1.16B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-75.20M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-91.81M | USD | Point-in-time |
| Total Bio-Techne's shareholders' equity |
StockholdersEquity
|
$1.70B | USD | Point-in-time |
| Total Bio-Techne's shareholders' equity |
StockholdersEquity
|
$1.75B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$-759.00K | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.57B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.75B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.70B | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.65B | USD | Point-in-time |
| Total liabilities and shareholders' equity |
LiabilitiesAndStockholdersEquity
|
$2.29B | USD | Point-in-time |
| Total liabilities and shareholders' equity |
LiabilitiesAndStockholdersEquity
|
$2.35B | USD | Point-in-time |
Income Statement
47 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$257.72M | USD | 1 Quarter |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$269.65M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$90.06M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$86.72M | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$171.00M | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$179.59M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$99.38M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$86.17M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$21.60M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$23.90M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$107.78M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$123.28M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$63.22M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$56.32M | USD | 1 Quarter |
| Other income (expense) |
NonoperatingIncomeExpense
|
$47.40M | USD | 1 Quarter |
| Other income (expense) |
NonoperatingIncomeExpense
|
$4.16M | USD | 1 Quarter |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$67.38M | USD | 1 Quarter |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$103.72M | USD | 1 Quarter |
| Income taxes (benefit) |
IncomeTaxExpenseBenefit
|
$-1.60M | USD | 1 Quarter |
| Income taxes (benefit) |
IncomeTaxExpenseBenefit
|
$13.98M | USD | 1 Quarter |
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$89.73M | USD | 1 Quarter |
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$68.98M | USD | 1 Quarter |
| Net earnings (loss) attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-634.00K | USD | 1 Quarter |
| Net earnings (loss) attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$179.00K | USD | 1 Quarter |
| Net earnings attributable to Bio-Techne |
NetIncomeLoss
|
$89.56M | USD | 1 Quarter |
| Net earnings attributable to Bio-Techne |
NetIncomeLoss
|
$69.61M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$-8.65M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$-21.46M | USD | 1 Quarter |
| Foreign currency translation reclassified to earnings with Eminence deconsolidation |
OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent
|
$119.00K | USD | 1 Quarter |
| Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8 |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
$1.68M | USD | 1 Quarter |
| Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8 |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
$4.70M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-6.96M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-16.64M | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to noncontrolling interest |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
|
$-33.00K | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to noncontrolling interest |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
|
$-39.00K | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to Bio-Techne |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-6.92M | USD | 1 Quarter |
| Other comprehensive income (loss) attributable to Bio-Techne |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-16.61M | USD | 1 Quarter |
| Comprehensive income attributable to Bio-Techne |
ComprehensiveIncomeNetOfTax
|
$72.94M | USD | 1 Quarter |
| Comprehensive income attributable to Bio-Techne |
ComprehensiveIncomeNetOfTax
|
$62.69M | USD | 1 Quarter |
| Basic |
EarningsPerShareBasic
|
$2.28 | USD | 1 Quarter |
| Basic |
EarningsPerShareBasic
|
$1.78 | USD | 1 Quarter |
| Diluted |
EarningsPerShareDiluted
|
$1.69 | USD | 1 Quarter |
| Diluted |
EarningsPerShareDiluted
|
$2.21 | USD | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
39.09M | shares | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
39.23M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
40.54M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
41.16M | shares | 1 Quarter |
Cash Flow Statement
81 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$89.73M | USD | 1 Quarter |
| Net earnings, including noncontrolling interest |
ProfitLoss
|
$68.98M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$26.64M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$24.73M | USD | 1 Quarter |
| Costs recognized on sale of acquired inventory |
FairValueWriteUpOfAcquiredInventory
|
$1.51M | USD | 1 Quarter |
| Costs recognized on sale of acquired inventory |
FairValueWriteUpOfAcquiredInventory
|
$300.00K | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$-4.77M | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$5.41M | USD | 1 Quarter |
| Stock-based compensation expense |
ShareBasedCompensation
|
$11.74M | USD | 1 Quarter |
| Stock-based compensation expense |
ShareBasedCompensation
|
$14.46M | USD | 1 Quarter |
| Fair value adjustment to contingent consideration payable |
FairValueAdjustmentToContingentConsiderationPayable
|
$-100.00K | USD | 1 Quarter |
| Fair value adjustment to contingent consideration payable |
FairValueAdjustmentToContingentConsiderationPayable
|
$-2.80M | USD | 1 Quarter |
| Contingent consideration payments - operating |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-3.30M | USD | 1 Quarter |
| (Gain) Loss on investment, net |
GainOnSaleOfInvestments
|
$37.18M | USD | 1 Quarter |
| (Gain) Loss on investment, net |
GainOnSaleOfInvestments
|
$5.28M | USD | 1 Quarter |
| Fair value adjustment on available for sale investments |
FairValueAdjustmentOnAvailableForSaleSecurities
|
$-911.00K | USD | 1 Quarter |
| Asset impairment restructuring |
AssetImpairmentRestructuringCharge
|
$546.00K | USD | 1 Quarter |
| Asset impairment restructuring |
AssetImpairmentRestructuringCharge
|
- | USD | 1 Quarter |
| Gain on sale of Eminence |
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
|
- | USD | 1 Quarter |
| Gain on sale of Eminence |
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
|
$11.68M | USD | 1 Quarter |
| Leases, net |
NoncashPortionOfLeaseExpense
|
$-79.00K | USD | 1 Quarter |
| Leases, net |
NoncashPortionOfLeaseExpense
|
$2.54M | USD | 1 Quarter |
| Other operating activity |
OtherOperatingActivitiesCashFlowStatement
|
$497.00K | USD | 1 Quarter |
| Other operating activity |
OtherOperatingActivitiesCashFlowStatement
|
$-32.00K | USD | 1 Quarter |
| Trade accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$-17.34M | USD | 1 Quarter |
| Trade accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$3.64M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$10.69M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$2.98M | USD | 1 Quarter |
| Prepaid expenses |
IncreaseDecreaseInPrepaidExpense
|
$2.76M | USD | 1 Quarter |
| Prepaid expenses |
IncreaseDecreaseInPrepaidExpense
|
$5.85M | USD | 1 Quarter |
| Trade accounts payable, accrued expenses, contract liabilities, and other |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-2.30M | USD | 1 Quarter |
| Trade accounts payable, accrued expenses, contract liabilities, and other |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-1.40M | USD | 1 Quarter |
| Salaries, wages and related accruals |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-28.36M | USD | 1 Quarter |
| Salaries, wages and related accruals |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-18.93M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$2.94M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-19.82M | USD | 1 Quarter |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$48.43M | USD | 1 Quarter |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$56.08M | USD | 1 Quarter |
| Proceeds from maturities of available-for-sale investments |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$12.45M | USD | 1 Quarter |
| Proceeds from maturities of available-for-sale investments |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$14.51M | USD | 1 Quarter |
| Purchases of available-for-sale investments |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$14.50M | USD | 1 Quarter |
| Purchases of available-for-sale investments |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$13.50M | USD | 1 Quarter |
| Proceeds from sale of CCXI investment |
ProceedsFromSaleOfEquitySecuritiesFvNi
|
$73.22M | USD | 1 Quarter |
| Additions to property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$9.56M | USD | 1 Quarter |
| Additions to property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$6.07M | USD | 1 Quarter |
| Acquisitions, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$101.18M | USD | 1 Quarter |
| Proceeds from sale of Eminence |
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
|
$17.82M | USD | 1 Quarter |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-19.69M | USD | 1 Quarter |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-7.12M | USD | 1 Quarter |
| Cash dividends |
PaymentsOfDividendsCommonStock
|
$12.54M | USD | 1 Quarter |
| Cash dividends |
PaymentsOfDividendsCommonStock
|
$12.49M | USD | 1 Quarter |
| Proceeds from stock option exercises |
ProceedsFromStockOptionsExercised
|
$37.88M | USD | 1 Quarter |
| Proceeds from stock option exercises |
ProceedsFromStockOptionsExercised
|
$11.95M | USD | 1 Quarter |
| Re-purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$19.56M | USD | 1 Quarter |
| Borrowings under line-of-credit agreement |
ProceedsFromLongTermLinesOfCredit
|
$449.66M | USD | 1 Quarter |
| Borrowings under line-of-credit agreement |
ProceedsFromLongTermLinesOfCredit
|
$10.00M | USD | 1 Quarter |
| Repayments of long-term debt |
RepaymentsOfLinesOfCredit
|
$441.00M | USD | 1 Quarter |
| Repayments of long-term debt |
RepaymentsOfLinesOfCredit
|
$51.12M | USD | 1 Quarter |
| Contingent consideration payments - financing |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
$700.00K | USD | 1 Quarter |
| Contingent consideration payments - financing |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
- | USD | 1 Quarter |
| Taxes paid on RSUs and net share settlements |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$17.85M | USD | 1 Quarter |
| Taxes paid on RSUs and net share settlements |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$23.25M | USD | 1 Quarter |
| Other financing activity |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-2.46M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-31.81M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-39.68M | USD | 1 Quarter |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$-11.90M | USD | 1 Quarter |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$-4.40M | USD | 1 Quarter |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-7.31M | USD | 1 Quarter |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-2.77M | USD | 1 Quarter |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$196.32M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$199.09M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$172.57M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$165.26M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$196.32M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$199.09M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$172.57M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$165.26M | USD | Point-in-time |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$14.89M | USD | 1 Quarter |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$12.07M | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$3.41M | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$3.11M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.